Literature DB >> 9378897

Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review.

A N Prasad1, J C Breen, M G Ampola, N P Rosman.   

Abstract

Argininemia, a rare autosomal recessive urea cycle disorder, is caused by a deficiency of arginase, with resulting elevated plasma arginine and ammonia levels. Reports to date have focused little on the neurology of this disorder or the efficacy of treatments. A MEDLINE search revealed 25 previously reported cases, to which we have added two brothers who presented with late onset progressive spastic diplegia. Though their degree of enzyme deficiency was comparable, the severity of their phenotypic abnormalities differed substantially. With dietary therapy, both showed improved cognitive and motor function. Late metabolic crises occurred in both, resulting in death of the less severely affected brother. Based on analysis of our clinical database, we report on the full spectrum of neurologic abnormalities seen in argininemia with particular focus on the accompanying progressive spastic diplegia and its response to treatment; progressive decline in head growth; distinctive neuroradiologic findings; and life-threatening later complications. Current and potential future therapies and long-term outcome are summarized.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378897     DOI: 10.1177/088307389701200502

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  25 in total

1.  Arginase deficiency presenting with cerebral oedema and failure to thrive.

Authors:  J W Harrington; M Stiefel; E Gianos
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

Review 2.  Cerebral palsy: not always what it seems.

Authors:  R Gupta; R E Appleton
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  Hyperargininemia: a family with a novel mutation in an unexpected site.

Authors:  Y Haimi Cohen; R Bargal; M Zeigler; T Markus-Eidlitz; V Zuri; A Zeharia
Journal:  JIMD Rep       Date:  2011-12-21

Review 4.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

Review 5.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

6.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

7.  A Case of Hyperargininaemia Presenting at Unusually Low Age.

Authors:  Vanita Lal; Daisy Khera; Garima Gupta; Kuldeep Singh; Praveen Sharma
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.

Authors:  Stephanie A K Angarita; Brian Truong; Suhail Khoja; Matthew Nitzahn; Abha K Rajbhandari; Irina Zhuravka; Sergio Duarte; Michael G Lin; Alex K Lam; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2018-04-21       Impact factor: 4.797

9.  Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts.

Authors:  Michael S Oldham; John W VanMeter; Kyle F Shattuck; Stephen D Cederbaum; Andrea L Gropman
Journal:  Pediatr Neurol       Date:  2010-01       Impact factor: 3.372

Review 10.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.